US2008206353A1PendingUtilityA1

Formulations And Treatments For Trichology

46
Assignee: PHILLIPS JONPriority: Dec 24, 2004Filed: Dec 20, 2005Published: Aug 28, 2008
Est. expiryDec 24, 2024(expired)· nominal 20-yr term from priority
Inventors:Jon Phillips
A61P 9/00A61P 3/00A61P 3/02A61P 17/14A61P 17/00A61K 8/9794A61K 8/9771A61K 8/9789A61K 8/9741A61K 36/48A61K 8/27A61Q 7/00A61K 31/10A61K 8/44A61K 2800/58A61K 8/58A61K 36/889A61K 36/736A61K 36/11A61K 8/4906A61K 36/258A61K 8/986A61K 36/704A61K 8/466A61K 36/16A61K 31/56A61K 8/63A61K 35/20
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

a formulation for trichological treatment of a patient including, in a dosage in the range of 3 g to 8 g: phytosterols in the range of 200 mg to 2500 mg; the quantitative equivalent of Polygonum multiflorum root 4:1 in 70% EW in the range of 600 mg to 2600 mg; methylsulfonylmethane in the range of 500 mg to 2000 mg; and bovine colostrum in the range of 500 m to 2000 m.

Claims

exact text as granted — not AI-modified
1 - 61 . (canceled) 
     
     
         62 . A formulation for trichological treatment including:
 a 5-alpha reductase production inhibitor selected from one or more phytosterols as equivalents to beta-sitosterol;   methylsulfonylmethane;   extract from the herbal variety  Polygonum multiflorum;  levo-arginine;   colostrum; and  Gingko biloba.      
     
     
         63 . The formulation for trichological treatment according to  claim 62 , wherein the formulation includes zinc amino acid chelate. 
     
     
         64 . The formulation for trichological treatment according to  claim 62  or  claim 63 , wherein the formulation includes any one or more extracts from the herbal varieties:
   Polygonum multiflorum;        Gingko biloba;        Equisetum arvense;        Panax quinquefolium.      
     
     
         65 . The formulation for trichological treatment according to  claim 64 , wherein the formulation includes any one or more of the following components:
 one or more soy isoflavones; levo-arginine;   inositol;   niacin;   biotin;   calcium pantothenate; dextro-alpha-tocopherol; Pyridoxine hydrochloride;   
     
     
         66 . The formulation for trichological treatment according to  claim 62 , wherein the colostrum is bovine colostrum. 
     
     
         67 . The formulation for trichological treatment according to  claim 62 , wherein the 5-alpha reductase production includes extract from  Serenoa repens.    
     
     
         68 . The formulation for trichological treatment according  claim 62 , and including  Pygeum repens.    
     
     
         69 . The formulation for trichological treatment according to  claim 62 , and including thiamine. 
     
     
         70 . The formulation for trichological treatment according to  claim 62 , and including riboflavin. 
     
     
         71 . A formulation for trichological treatment of a patient including, in a dosage in the range of 3 g to 8 g:
 phytosterols as equivalents to beta-sitosterol in the range of 200 mg to 2500 mg;   the quantitative equivalent of  Polygonum multiflorum  root 4:1 in 70% EW in the range of 600 mg to 2600 mg;   methylsulfonylmethane in the range of 500 mg to 2000 mg; bovine colostrum in the range of 500 mg to 2000 mg; and   the quantitative equivalent of  Gingko biloba  leaf extract 50:1 in 70% EW in the range of 50 mg to 1000 mg.   
     
     
         72 . A formulation for trichological treatment according to  claim 71 , and further including the quantitative equivalent of zinc amino acid chelate 20% in the range of 10 mg to 40 mg. 
     
     
         73 . The formulation for trichological treatment according to  claim 71  or  claim 72 , and including any one or more of the following components:
 arginine in the range of 120 mg to 500 mg; biotin in the range of 0.7 mg to 5 mg;   nicotinic acid in the range of 5 mg to 30 mg; calcium pantothenate in the range of 10 mg to 400 mg;   pyridoxine hydrochloride in the range of 10 mg to 400 mg; d-a-tocopherol acetate in the range of 200 Hi to 800 IU; and colloidal anhydrous silica in the range of 6O mg to 500 mg.   
     
     
         74 . The formulation for trichological treatment according to  claim 71 , and including any one or more of the following components:
 the quantitative equivalent of Glycine Max (soy) seed 65:1 in 75% EW in the range of 80 mg to 3250 mg;   the quantitative equivalent of  Panax quinquefolium  root extract 3:1 in 15% EW in the range of 50 mg to 1000 mg;   the quantitative equivalent of  Equisetum arvense  herb extract 4:1 in 100% water in the range of 50 mg to 1000 mg;   inositol in the range of 70 mg to 300 mg;   
     
     
         75 . The formulation for trichological treatment according to  claim 71 , wherein the phytosterols are in the range of 200 mg to 2500 mg. 
     
     
         76 . The formulation for trichological treatment according to  claim 71 , wherein the phytosterols are in the range of 200 mg to 1000 mg. 
     
     
         77 . The formulation for trichological treatment according to  claim 71 , wherein the  Gingko biloba  extract is in the range of 50 mg to 1000 mg. 
     
     
         78 . The formulation for trichological treatment according to  claim 71 . wherein the  Gingko biloba  extract is in the range of 50 mg to 500 mg. 
     
     
         79 . The formulation for trichological treatment according to any one of  claim 74 , wherein the  Panax quinquefolium  root extract is in the range of 50 mg to 1000 mg. 
     
     
         80 . The formulation for trichological treatment according to  claim 74 , wherein the  Panax quinquefolium  root extract is in the range of 50 mg to 500 mg. 
     
     
         81 . The formulation for trichological treatment according to  claim 74 , wherein the  Equisetum arvense  herb extract is in the range of 50 mg to 1000 mg. 
     
     
         82 . The formulation for trichological treatment according to  claim 74 , wherein the  Equisetum arvense  herb extract is in the range of 50 mg to 500 mg. 
     
     
         83 . The formulation for trichological treatment according to  claim 71 , wherein the bovine colostrum is in the range of 50 mg to 2000 mg. 
     
     
         84 . The formulation for trichological treatment according to  claim 73 , wherein the bovine colostrum is in the range of 500 mg to 1000 mg. 
     
     
         85 . The formulation for trichological treatment according to  claim 73 , wherein the biotin is in the range of 0.7 mg to 3 mg. 
     
     
         86 . The formulation for trichological treatment according to  claim 73 , wherein the pyridoxine hydrochloride is in the range of 100 mg to 400 mg. 
     
     
         87 . A medicinal formulation for trichological treatment including:
 extracts from the herbal varieties:     Polygonum multiflorum;        Gingko biloba;        Equisetum arvense;        Panax quinquefolium;      methylsulfonylmethane;   levo-arginine;   a 5-alpha reductase production inhibitor; one or more soy isoflavones;   inositol;   niacin;   biotin;   calcium pantothenate;   dextro-alpha-tocopherol;   pyridoxine hydrochloride;   zinc amino acid chelate; and colostrum.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.